Recombinant human granulocyte-macrophage colony-stimulating factor: Effect of glycosylation on pharmacokinetic parameters

Electronic Journal of Biotechnology

Volumn 10, Issue 2, 2007, Pages 271-278

  Marini, Guillermo ^a   Forno, Guillermina ^a   Kratje, Ricardo ^a   Etcheverrigaray, Marina ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Glycosylation; Pharmacokinetic parameters; rhGM CSF

Indexed keywords

CONCENTRATION (PROCESS); ESCHERICHIA COLI; GLYCOSYLATION; MAMMALS; PHARMACOKINETICS;

BIPHASIC KINETICS; PHARMACOKINETIC PARAMETERS; RODENTS;

VIRUSES;

CARBOHYDRATE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; GLYCOSYLATION; MALE; MOUSE; NONHUMAN; PARAMETER; RAT; SINGLE DRUG DOSE;

MAMMALIA; RODENTIA;

EID: 34247588135     PISSN: None     EISSN: 07173458     Source Type: Journal    
DOI: 10.2225/vol10-issue2-fulltext-5     Document Type: Article

References (25)

1. ARMITAGE, James O. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood, December 1998, vol. 92, no. 12, p. 4491-4508.
2. BILGIN, Kemal; YARAMIS, Ahmet; HASPOLAT, Kenan; TAS, M. Ali; GUNBEY, Sacit and DERMAN, Orhan. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics, January 2001, vol. 107, no. 1, p. 36-41.
3. BOLLATI FOGOLÍN, Mariela; OGGERO EBERHARDT, Marcos; KRATJE, Ricardo and ETCHEVERRIGARAY, Marina. Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems. Electronic Journal of Biotechnology [on line]. 15 December 2002, vol. 5, no. 3. Available from: http://www.ejbiotechnology.info/content/vol5/issue3/full/ 6/index.html. ISSN 0717-3458.
4. BOLLATI FOGOLÍN, Mariela; WAGNER, Roland; ETCHEVERRIGARAY, Marina and KRATJE, Ricardo. Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO cells. Journal of Biotechnology, April 2004, vol. 109, no. 1-2, p. 179-191.
5. CEBON, Jonathan; NICOLA, Nicos; WARD, Marcia; GARDNER, Ian; DEMPSEY, Peter; LAYTON, Judith; DÜHRSEN, Ulrich; BURGESS, Antony; NICE, Edouard and MORSTYN, George. Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity. The Journal of Biological Chemistry, March 1990, vol. 265, no. 8, p. 4483-4491.
6. CHITLARU, Theodor; KRONMAN, Chanoch; VELAN, Baruch and SHAFFERMAN, Avigdor. Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time. Biochemical Journal, May 2002, vol. 363, no. 3, p. 619-631.
7. DENZLINGER, C.; TETZLOFF, W.; GERHARTZ, H.H.; POKORNY, R.; SAGEBIEL, S.; HABERL, C. and WILMANNS, W. Differential activation of the endogenous leukotriene biosynthesis by two different preparations of granulocyte-macrophage colony-stimulating factor in healthy volunteers. Blood, April 1993, vol. 81, no. 8, p. 2007-2013.
8. DORR, Robert T. Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor. Clinical Therapeutics, January-February 1993, vol. 15, no. 1, p. 19-29.
9. EGRIE, Joan C. and BROWNE, Jeffrey K. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrology Dialysis Transplantation, June 2001, vol. 16, no. 3, p. 3-13.
10. FORNO, Guillermina; BOLLATI FOGOLÍN, Mariela; OGGERO, Marcos; KRATJE, Ricardo; ETCHEVERRIGARAY, Marina; CONRADT, Harald S. and NIMTZ, Manfred. N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line. European Journal of Biochemistry, March 2004, vol. 271, no. 5, p. 907-919.
11. FLEETWOOD, Andrew J.; COOK, Andrew D. and HAMILTON, John A. Functions of granulocyte-macrophage colony-stimulating factor. Critical Reviews in Immunology, 2005, vol. 25, no. 5, p. 405-428.
12. GRIBBEN, J.G.; DEVEREUX, S.; THOMAS, N.S.B.; KEIM, M.; JONES, H.M.; GOLDSTONE, A.H. and LINCH, D.C. Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF. Lancet, February 1990, vol. 335, no. 8687, p. 434-437.
13. HUSSEIN, Atif M.; ROSS, Maureen; VREDENBURGH, James; MEISENBERG, Barry; HARS, Vera; GILBERT, Colleen; PETROS, William P.; CONIGLIO, David; KURTZBERG, Joanne; RUBIN, Peter and PETERS, William P. Effects of granulocyte-macrophage colony stimulating factor produced in CHO cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. European Journal of Haematology, November 1995, vol. 54, no. 5, p. 281-287.
14. KAUSHANSKY, Kenneth; O'HARA, Patrick J.; HART, Charles E.; FORSTROM, John W. and HAGEN, Frederick S. Role of carbohydrate in the function of human granulocyte-macrophage colony-stimulating factor. Biochemistry, July 1987, vol. 26, no. 15, p. 4861-4867.
15. KOURY, Mark J. Sugar coating extends half-lives and improves effectiveness of cytokine hormones. Trends in Biotechnology, November 2003, vol. 21, no. 11, p. 462-464.
16. MITRA, Nivedita; SINHA, Sharmistha; RAMYA, Thirumalai N.C. and SUROLIA, Avadhesha. N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. Trends in Biochemical Sciences, March 2006, vol. 31, no. 3, p. 156-163.
17. PARK, Eric I. and BAENZIGER, Jacques U. Closely related mammals have distinct asialoglycoprotein receptor carbohydrate specificities. The Journal of Biological Chemistry, September 2004, vol. 279, no. 39, p. 40954-40959.
18. REVOLTELLA, Roberto P.; LARICCHIA-ROBBIO, Leopoldo; MOSCATO, Stefania; GENUA, Angelo and LIBERATI, Anna M. Natural and therapy-induced anti-GM-CSF and anti-G-CSF antibodies in human serum. Leukemia and Lymphoma, December 1997, vol. 26, no. 1, p. 29-34.
19. RUDD, Pauline M.; ELLIOTT, Tim; CRESSWELL, Peter; WILSON, Ian A. and DWEK, Raymond A. Glycosylation and the immune system. Science, March 2001, vol. 291, no. 5512, p. 2370-2376.
20. th ed. New Baskerville, McGraw-Hill, 2005. 892 p. ISBN 0-07-137550-3.
21. STUTE, Norbert; FURMAN, Wayne L.; SCHELL, Michael and EVANS, William E. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration. Journal of Pharmaceutical Sciences, July 1995, vol. 84, no. 7, p. 824-828.
22. TRINDADE, Eunice; MATON, Pierre; REDING, Raymond; DE VILLE DE GOYET, Jean; OTTE, Jean Bernard; BUTS, Jean Paul and SOKAL, Etienne M. Use of granulocyte macrophage colony stimulating factor in children after orthotopic liver transplantation. Journal of Hepatology, June 1998, vol. 28, no. 6, p. 1054-1057.
23. WADHWA, Meenu; BIRD, Chris; FAGERBERG, Jan; GAINES-DAS, Rose; RAGNHAMMAR, Peter; MELLSTEDT, Hakan and THORPE, Robin. Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy. Clinical and Experimental Immunology, May 1996, vol. 104, no. 2, p. 351-358.
24. WADHWA, Meenu; HJELM SKOG, Anna-Lena; BIRD, Chris; RAGNHAMMAR, Peter; LILLJEFORS, Maria; GAINES-DAS, Rose; MELLSTEDT, Hakan and THORPE, Robin. Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF. Clinical Cancer Research, June 1999, vol. 5, no. 6, p. 1353-1361.
25. WALSH, Gary. Biopharmaceutical benchmarks - 2003. Nature Biotechnology, August 2003, vol. 21, no. 8, p. 865-870.